Canary Cure Therapeutics
PrivateLast Round
Series A
Jul 10, 2025
Company Overview
Canary Cure Therapeutics operates in Healthcare & Life Sciences and is based in Burlington. Its latest recorded funding round was a Grant round in September 2023.
Canary Cure Therapeutics is a biotechnology company that develops RNA-based therapeutics and companion diagnostics for the treatment of obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Canary Cure Therapeutics Comparables
Compare Canary Cure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argonaute RNA | 82% | |
| Sanegene Bio | 80% | |
| Argo Biopharma | 76% |
For institutional investors. Book with your work email.
Canary Cure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 10, 2025 | ||||
| Grant | Sep 9, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 37% MoM.
- Mar 2, 2026
Monthly visitors increased 36% MoM, reaching 1K.
For institutional investors. Book with your work email.
Canary Cure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Canary Cure Therapeutics's valuation, stock price, and market status.
Is Canary Cure Therapeutics a public or private company?
Canary Cure Therapeutics is a private company.
What is the current stock price of Canary Cure Therapeutics?
Canary Cure Therapeutics is a private company, so its shares have no public market price. Caplight tracks Canary Cure Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Canary Cure Therapeutics worth (valuation)?
Valuation information for Canary Cure Therapeutics is not publicly available.
Can I buy Canary Cure Therapeutics stock?
Canary Cure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Canary Cure Therapeutics's last funding round?
Canary Cure Therapeutics's most recent funding round was Series A on July 10, 2025.
Who are the main investors in Canary Cure Therapeutics?
Investor information for Canary Cure Therapeutics is not publicly disclosed.
Will Canary Cure Therapeutics IPO soon?
No public IPO plans have been announced for Canary Cure Therapeutics.
How can I track Canary Cure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Canary Cure Therapeutics's shares on secondary markets.